|
15th Annual Conference of the British HIV Association1-3 April 2009, Liverpool, UK |
ASSESSMENT OF THE IMPACT OF A HOME DELIVERY SERVICE ON THE VIROLOGICAL OUTCOME OF PATIENTS WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV)
HIV Med 2009 Apr 1-3; 10(Suppl. 1):15 (abstract no. P3)
H Papineni1, S Castelino2 and C Jones1
1Pharmacy Department, King’s College London, London, UK, 2Pharmacy & HIV Unit, Guy’s & St Thomas’ NHS Foundation Trust, London, UK
BACKGROUND: Successful treatment of HIV requires a high level of patient adherence to anti-retroviral (ARV) therapy. Compliance is likely to be improved by making treatment more convenient. Since 2005 a home delivery of HIV medicines service that enhanced patient convenience has been available for registered patients at a HIV unit. This study assesses its impact on patient outcome as indicated by HIV viral load.
METHODS: Retrospective analysis of case notes from a random sample of 500 patients. Patients were categorised into 5 groups based on their home delivery status: (1) on home delivery; (2) put on hold because of virological or clinical instability; (3) offered the service but declined; (4) never offered the service and (5) withdrawn from the service. Data collected included: gender, age, year of registration with the clinic, current ARV therapy, HIV viral load, prescriber details and type of HIV treatment regime. Data collected was analysed statistically using the Chi-squared test.
RESULTS: Sixty-eight percent (n=341) of the sample were male with the age of patients included having a negative skewed distribution. The year of registration with the clinic was significantly associated with their home delivery status (P=0.01). Sixty-seven percent of patients on the home delivery service registered with the clinic more than 5 years ago. Ninety-three percent of the patients on the home delivery service had been on the same ARV treatment regimen for 3–6 months, a required criterion for inclusion on the service. More than half of the patients sampled (54%, n=268) were on a nucleoside reverse transcriptase inhibitor and non nucleoside reverse transcriptase inhibitor combination. There was a significant association between patients home delivery status and detectable HIV viral load in the past year (P=0.001).
CONCLUSIONS: The study found that there was no significant difference in the HIV viral load between patients who had their AVR medicines home delivered and patients that were suitable but declined to join the service, indicating they have similar patient outcomes.
2009-04-01
P3
Copyright © 2009 - British HIV Association (BHIVA) Reproduction of this abstract (other than one copy for personal reference) must be cleared through the BHIVA Organising Secretariat 1 Mountview Court, 310 Friern Barnet Lane, London N20 0LD